Adutos de carboxilatos de ródio com nitroimidazóis: síntese, caracterização e avaliação de potencial antichagásico

Nothenberg, Michael Simon.
São Paulo; s.n; 1989. 160 p. ilus.
Tesis en Portugués | LILACS, Coleciona SUS (Brasil) | ID: biblio-938393

Documentos relacionados

  1. Pharmacokinetics of Benznidazole in Experimental Chronic Chagas Disease Using the Swiss Mouse-Berenice-78 Trypanosoma cruzi Strain Model.
  2. Reduced Trypanosoma cruzi-specific humoral response and enhanced T cell immunity after treatment interruption with benznidazole in chronic Chagas disease.
  3. Efficacy of continuous versus intermittent administration of nanoformulated benznidazole during the chronic phase of Trypanosoma cruzi Nicaragua infection in mice.
  4. Population pharmacokinetics and biodistribution of benznidazole in mice.
  5. Benznidazole, itraconazole, and their combination for the treatment of chronic experimental Chagas disease in dogs.
  6. Benzonidazole treatment has a beneficial effect on cells infected with the Colombian strain of Trypanosoma cruzi.
  7. Lychnopholide loaded in surface modified polylactide nanocapsules (LYC-PLA-PEG-NC) cure mice infected by Trypanosoma cruzi strain a prototype of resistance to benznidazole and nifurtimox: First insights of its mechanism of action.
  8. Combination Therapy Using Benznidazole and Aspirin during the Acute Phase of Experimental Chagas Disease Prevents Cardiovascular Dysfunction and Decreases Typical Cardiac Lesions in the Chronic Phase.
  9. Effect of B-NIPOx in Experimental <i>Trypanosoma cruzi</i> Infection in Mice.
  10. Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi <i>In Vitro</i> and <i>In Vivo</i>.